Deltex Medical Group PLC Issue of Equity (8795V)
April 11 2023 - 12:43PM
UK Regulatory
TIDMDEMG
RNS Number : 8795V
Deltex Medical Group PLC
11 April 2023
11 April 2023
Deltex Medical Group plc
("Deltex Medical", the "Company" or the "Group")
Issue of equity to satisfy certain outstanding equity-settled
non-executive directors' fees
The Board of Deltex Medical (AIM: DEMG), the global leader in
oesophageal doppler monitoring, announces the issue of 9,993,805
new ordinary shares of 1p each in the capital of the Company
("Ordinary Shares"), at an issue price of 1.1 pence per new
Ordinary Share (the "Issue Price"). The Issue Price represents the
Company's closing mid-market price on 6 April 2023.
The new Ordinary Shares are being issued in order to satisfy
certain deferred non-executive directors' fees for the year ended
31 December 2021 ("Fee Shares"). In previous years, the Company has
settled the deferred non-executive directors' fees of a calendar
year in July of the following year. This was last done on 16 July
2021 in respect of the fees ended 31 December 2020. The fees for
the year ended 31 December 2021 were expected to be settled on or
around July 2022. However, the Company was in and has continued to
be in a closed period since that time. Following the publication of
the results for the year ended 31 December 2022, the Company is now
in a position to settle such outstanding non-executive directors'
fees.
Further details of the new Ordinary Shares to be issued to each
of the Deltex Medical directors are set out in the table below.
Resultant holding post Fee
Shares
--------------------------------
Director Current Ordinary Fee Shares Ordinary As a percentage
Shares held issued Shares Held of the enlarged
share capital
Nigel Keen 99,852,821 3,448,351 103,301,172 14.57%
Julian Cazalet 27,153,971 2,181,818 29,335,789 4.14%
Mark Wippell 11,037,875 2,181,818 13,219,693 1.86%
Chris Jones 4,297,291 2,181,818 6,479,109 0.91%
Application for admission to trading and total voting rights
Application has been made for 9,993,805 new Ordinary Shares to
be admitted to trading on AIM, which is expected to take effect on
or around 17 April 2023 ("Admission").
Following Admission, the Company's issued share capital will
comprise 709,057,601 Ordinary Shares. The Company does not hold any
Ordinary Shares in treasury. This figure may be used by
shareholders in the Company as the denominator for the calculations
by which they will determine if they are required to notify their
interest in, or a change to their interest in, the share capital of
the Company under the Financial Conduct Authority's Disclosure
Guidance and Transparency Rules.
For further information, please contact:
Deltex Medical Group plc 01243 774 837
Nigel Keen, Chairman investorinfo@Deltexmedical.com
Andy Mears, Chief Executive
Natalie Wettler, Group Finance Director
Nominated Adviser and Broker
Allenby Capital Limited 020 3328 5656
Jeremy Porter / Vivek Bhardwaj (Corporate info@allenbycapital.com
Finance)
Tony Quirke / Stefano Aquilino (Sales
& Corporate Broking)
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them:
1. Details of the person discharging managerial responsibilities
/ person closely associated
a) Name PDMRs: Nigel Keen Non-Executive Director
- Chairman
Julian Cazalet Non-Executive Director
-----------------------
Mark Wippell Non-Executive Director
-----------------------
Chris Jones Non-Executive Director
-----------------------
-------------------------------- -----------------------------------------------
2. Reason for the Notification
---------------------------------------------------------------------------------
a) Position/status See 1a) above
-------------------------------- -----------------------------------------------
b) Initial notification/Amendment Initial Notification
-------------------------------- -----------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
---------------------------------------------------------------------------------
a) Name Deltex Medical Group Plc
-------------------------------- -----------------------------------------------
b) LEI 213800XN34P6LI8J6M39
-------------------------------- -----------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
---------------------------------------------------------------------------------
a) Description of Ordinary shares of 0.1p each in
the Financial Deltex Medical Group Plc
instrument, type
of instrument
-------------------------------- -----------------------------------------------
Identification ISIN: GB0059337583
code
-------------------------------- -----------------------------------------------
b) Nature of the Fee shares
transaction
-------------------------------- -----------------------------------------------
c) Price(s) and volume(s) Name Price(s) Volume(s)
Nigel Keen 1.1p 3,448,351
--------- ----------
Julian Cazalet 1.1p 2,181,818
--------- ----------
Mark Wippell 1.1p 2,181,818
--------- ----------
Chris Jones 1.1p 2,181,818
--------- ----------
-------------------------------- -----------------------------------------------
d) Aggregated information:
-------------------------------- -----------------------------------------------
* Aggregated volume 9,993,805
------------------------------------- -----------------------------------------------
* Price 1.1p
------------------------------------- -----------------------------------------------
e) Date of the transaction 11 April 2023
-------------------------------- -----------------------------------------------
f) Place of the transaction Outside a trading venue
-------------------------------- -----------------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
IOESFAFMFEDSEDL
(END) Dow Jones Newswires
April 11, 2023 12:43 ET (16:43 GMT)
Deltex Medical (LSE:DEMG)
Historical Stock Chart
From Apr 2024 to May 2024
Deltex Medical (LSE:DEMG)
Historical Stock Chart
From May 2023 to May 2024